{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:29:26Z","timestamp":1792268966971,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","award":["0511RC03"],"award-info":[{"award-number":["0511RC03"]}],"id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","award":["0711RC26"],"award-info":[{"award-number":["0711RC26"]}],"id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","award":["0811RC02"],"award-info":[{"award-number":["0811RC02"]}],"id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","award":["0911RC02"],"award-info":[{"award-number":["0911RC02"]}],"id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","award":["0611RC19"],"award-info":[{"award-number":["0611RC19"]}],"id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","award":["0411RC08"],"award-info":[{"award-number":["0411RC08"]}],"id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1378\/chest.12-2820","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T09:32:03Z","timestamp":1370511123000},"page":"990-998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Incidence and Risk Factors of Legionella pneumophila Pneumonia During Anti-Tumor Necrosis Factor Therapy"],"prefix":"10.1016","volume":"144","author":[{"given":"Fanny","family":"Lanternier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tubach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philppe","family":"Ravaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dellamonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Bretagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Couret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Bouvard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Debandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gueit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dider","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1378\/chest.12-2820_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/039463200902200301","article-title":"Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events","volume":"22","author":"Murdaca","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"10","key":"10.1378\/chest.12-2820_bib2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1286-4579(00)01282-X","article-title":"The divergent role of tumor necrosis factor receptors in infectious diseases","volume":"2","author":"Schl\u00fcter","year":"2000","journal-title":"Microbes Infect"},{"issue":"3","key":"10.1378\/chest.12-2820_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1378\/chest.12-2820_bib4","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"G\u00f3mez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1378\/chest.12-2820_bib5","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"15","key":"10.1378\/chest.12-2820_bib6","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1378\/chest.12-2820_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","article-title":"Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry","volume":"70","author":"Salmon-Ceron","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1378\/chest.12-2820_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1086\/648724","article-title":"Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy","volume":"50","author":"Hage","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1378\/chest.12-2820_bib9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2165\/00003495-200969110-00002","article-title":"Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy","volume":"69","author":"Smith","year":"2009","journal-title":"Drugs"},{"issue":"2","key":"10.1378\/chest.12-2820_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)60839-2","article-title":"Fungal infections complicating tumor necrosis factor alpha blockade therapy","volume":"83","author":"Tsiodras","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1378\/chest.12-2820_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1378\/chest.12-2820_bib12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1086\/587989","article-title":"Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network","volume":"46","author":"Winthrop","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1378\/chest.12-2820_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semarthrit.2009.09.001","article-title":"Tumor necrosis factor inhibitors and lung disease: a paradox of efficacy and risk","volume":"40","author":"Khasnis","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1378\/chest.12-2820_bib14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1462-5822.2008.01145.x","article-title":"Host cell processes that influence the intracellular survival of Legionella pneumophila","volume":"10","author":"Shin","year":"2008","journal-title":"Cell Microbiol"},{"issue":"9","key":"10.1378\/chest.12-2820_bib15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1086\/586741","article-title":"Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia","volume":"46","author":"von Baum","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1378\/chest.12-2820_bib16","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1086\/508538","article-title":"Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists","volume":"43","author":"Tubach","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1378\/chest.12-2820_bib17","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.ijid.2010.09.007","article-title":"Progress in the surveillance and control of Legionella infection in France, 1998-2008","volume":"15","author":"Campese","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1378\/chest.12-2820_bib18","first-page":"365","article-title":"Cases of legionnaires' diseases in France in 2006","volume":"43","author":"Campese","year":"2007","journal-title":"Bull Epidemiol hebd"},{"issue":"10","key":"10.1378\/chest.12-2820_bib19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/ard.2006.062760","article-title":"Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists","volume":"66","author":"Askling","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"10.1378\/chest.12-2820_bib20","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"issue":"9","key":"10.1378\/chest.12-2820_bib21","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/art.22808","article-title":"Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1378\/chest.12-2820_bib22","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","article-title":"Infections in patients with rheumatoid arthritis treated with biologic agents","volume":"52","author":"Listing","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1378\/chest.12-2820_bib23","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1378\/chest.12-2820_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.micpath.2004.10.002","article-title":"Expression of IL-6 and TNF-alpha in human alveolar epithelial cells is induced by invading, but not by adhering, Legionella pneumophila","volume":"37","author":"Chang","year":"2004","journal-title":"Microb Pathog"},{"issue":"3","key":"10.1378\/chest.12-2820_bib25","first-page":"191","article-title":"Tumor necrosis factor induces resistance of macrophages to Legionella pneumophila infection","volume":"224","author":"McHugh","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"issue":"11","key":"10.1378\/chest.12-2820_bib26","doi-asserted-by":"crossref","first-page":"e1000665","DOI":"10.1371\/journal.ppat.1000665","article-title":"Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila","volume":"5","author":"Monroe","year":"2009","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1378\/chest.12-2820_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"3 pt 1","key":"10.1378\/chest.12-2820_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1164\/ajrccm.149.3.8118629","article-title":"Risk factors for nosocomial Legionella pneumophila pneumonia","volume":"149","author":"Carratala","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.12-2820_bib29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ije\/16.3.466","article-title":"Epidemiological survey of a major outbreak of nosocomial legionellosis","volume":"16","author":"Guiguet","year":"1987","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1378\/chest.12-2820_bib30","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3201\/eid1404.070961","article-title":"Lorraine strain of Legionella pneumophila serogroup 1, France","volume":"14","author":"Ginevra","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1378\/chest.12-2820_bib31","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/ibd.20866","article-title":"Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease","volume":"15","author":"Beigel","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1378\/chest.12-2820_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.crohns.2010.08.006","article-title":"Legionella pneumophila pneumonia in a pregnant woman treated with anti-TNF-\u03b1 antibodies for Crohn's disease: a case report","volume":"4","author":"Epping","year":"2010","journal-title":"J Crohn's Colitis"},{"issue":"6","key":"10.1378\/chest.12-2820_bib33","first-page":"775","article-title":"A severe complication of anti-TNF alfa treatment","volume":"145","author":"Fabroni","year":"2010","journal-title":"G Ital Dermatol Venereol"},{"issue":"12","key":"10.1378\/chest.12-2820_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1155\/2009\/836938","article-title":"Fulminant legionellosis in two patients treated with infliximab for Crohn's disease: case series and literature review","volume":"23","author":"Hofmann","year":"2009","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"10.1378\/chest.12-2820_bib35","first-page":"109","article-title":"First reported United States case of Legionella pneumophila serogroup 1 pneumonia in a patient receiving anti-tumor necrosis factor-alpha therapy","volume":"68","author":"Jinno","year":"2009","journal-title":"Hawaii Med J"},{"issue":"9","key":"10.1378\/chest.12-2820_bib36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0761-8425(07)74271-7","article-title":"Anti-TNF alpha therapy: a risk factor for legionella infection [in French]","volume":"24","author":"Lagier","year":"2007","journal-title":"Rev Mal Respir"},{"issue":"2","key":"10.1378\/chest.12-2820_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.rhu.0000158527.20518.30","article-title":"Pneumonitis caused by Legionella pneumoniae in a patient with rheumatoid arthritis treated with anti-TNF-alpha therapy (infliximab)","volume":"11","author":"Li Gobbi","year":"2005","journal-title":"J Clin Rheumatol"},{"issue":"10","key":"10.1378\/chest.12-2820_bib38","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1469-0691.2007.01796.x","article-title":"Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment","volume":"13","author":"Mancini","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"13","key":"10.1378\/chest.12-2820_bib39","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/jama.2011.1387","article-title":"Growing list of infections linked to TNF blockers","volume":"306","author":"Kuehn","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1378\/chest.12-2820_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/S0950268803008616","article-title":"Repeat capture-recapture studies as part of the evaluation of the surveillance of Legionnaires' disease in France","volume":"131","author":"Nardone","year":"2003","journal-title":"Epidemiol Infect"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213606170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213606170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:38:59Z","timestamp":1757918339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369213606170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0012369213606170"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-2820","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Risk Factors of Legionella pneumophila Pneumonia During Anti-Tumor Necrosis Factor Therapy","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-2820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}